National Research Council, Brazil Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2015
NCT02693366
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Research Council, Brazil

Active Ingredients

Drugs in Phase 2 Trials (1)

nitazoxanide (Alinia) (2 trials)

Drugs in Phase 1 Trials (1)

cardiamp (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Glomerulosclerosis, Focal Segmental (Phase 1)

Kidney Diseases (Phase 1)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Renal Insufficiency, Chronic (Phase 1)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2